Literature DB >> 6096685

Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.

A Poryo, R Wigand.   

Abstract

Guinea pigs were infected cutaneously with HSV1 and treated topically with acyclovir or phosphonoformic acid (0.1% to 0.5% solution), or with a combination of both. The therapy was clinically effective and the virus content in the skin diminished. Virus harvests from skin areas in no case showed increased drug resistance, as tested by plaque reduction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096685     DOI: 10.1007/bf02122113

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  28 in total

1.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Guinea pig model for cutaneous herpes simplex virus infection.

Authors:  W R Hubler; T D Felber; D Troll; M Jarratt
Journal:  J Invest Dermatol       Date:  1974-02       Impact factor: 8.551

3.  Combined antiviral effect of DNA inhibitors on Herpes simplex virus multiplication.

Authors:  R Wigand; M Hassinger
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

4.  Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.

Authors:  S E Straus; H E Takiff; M Seidlin; S Bachrach; L Lininger; J J DiGiovanna; K A Western; H A Smith; S N Lehrman; T Creagh-Kirk
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

5.  Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child.

Authors:  C D Sibrack; L T Gutman; C M Wilfert; C McLaren; M H St Clair; P M Keller; D W Barry
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

6.  Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs.

Authors:  S Alenius; B Oberg
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

8.  In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).

Authors:  K O Smith; W L Kennell; R H Poirier; F T Lynd
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.

Authors:  H J Field; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

10.  Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.

Authors:  C Janz; R Wigand
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.